2025,Nakatani S, Hayashi T, Hosaka A, Maeda H. Prognostic value of HER2 discordance between primary and metastatic or recurrent breast cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2025 Nov 11;217:105016. doi: 10.1016/j.critrevonc.2025.105016. Epub ahead of print. PMID: 41232824.